Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell Function

Recruiting Observational Study
Obesity, Childhood Type 2 Diabetes Mellitus in Obese
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 16
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Philippe Klee, MD-PhD · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The investigators will measure blood levels of 1,5-anhydroglucitol in obese children with or without type 2 diabetes and correlate them with parameters related to functional beta-cell mass and glucose metabolism. The values will be compared to those obtained in healthy volunteers. The aim of the study is to test the validity of 1,5-anhydroglucitol as a novel biomarker of beta-cell mass and functio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Children aged 12 to 16 years * Obesity. Defined as a body-mass index above the 97th percentile. * Ability to give informed consent as documented by signature Exclusion Criteria: * Patients with diabetes mellitus and positive autoantibodies against islets, insulin, islet anti…
Contacts

Philippe Klee

+41 79 55 33 476

philippe.klee@unige.ch

CONTACT

Pierre Maechler

pierre.maechler@unige.ch

CONTACT